当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:46.71亿  总市值:48.07亿
流通股本:3.00亿   总股本:3.09亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金321,094,641.931,457,801,783.561,008,713,306.08673,934,084.11
  收到的税费返还30,114.2227,273.8315,589.0615,589.06
  收到其他与经营活动有关的现金11,159,047.26138,292,035.05113,108,957.1691,600,684.59
  经营活动现金流入小计332,283,803.411,596,121,092.441,121,837,852.3765,550,357.76
  购买商品、接受劳务支付的现金107,442,961.56411,270,616.98278,438,685.88187,109,163.8
  支付给职工以及为职工支付的现金78,457,393.81280,533,714.05188,895,414.86127,605,321.31
  支付的各项税费36,948,912.02190,205,081.14160,625,209.47120,308,589.82
  支付其他与经营活动有关的现金108,445,815.71466,615,029.56369,058,945.53260,696,456.71
  经营活动现金流出小计331,295,083.11,348,624,441.73997,018,255.74695,719,531.64
  经营活动产生的现金流量净额988,720.31247,496,650.71124,819,596.5669,830,826.12
二、投资活动产生的现金流量:
  收回投资收到的现金490,495,0003,110,464,041.672,310,230,0001,934,975,000
  取得投资收益收到的现金3,435,470.13204,356,90439,226,845.8513,074,424.34
  处置固定资产、无形资产和其他长期资产收回的现金净额-2,930,780.8943,442.0837,442.08
  处置子公司及其他营业单位收到的现金净额--00
  收到的其他与投资活动有关的现金--50,000,00050,000,000
  投资活动现金流入小计493,930,470.133,317,751,726.562,399,500,287.931,998,086,866.42
  购建固定资产、无形资产和其他长期资产支付的现金2,756,741.637,459,304.5917,353,946.9412,173,916.33
  投资支付的现金461,634,110.143,440,575,0002,725,230,0002,269,975,000
  取得子公司及其他营业单位支付的现金-6,991,8556,991,855-
  支付其他与投资活动有关的现金-12,50012,50013,281.09
  投资活动现金流出小计464,390,851.743,485,038,659.592,749,588,301.942,282,162,197.42
  投资活动产生的现金流量净额29,539,618.39-167,286,933.03-350,088,014.01-284,075,331
三、筹资活动产生的现金流量:
  吸收投资收到的现金-68,681,90061,104,30061,104,300
  取得借款收到的现金-24,314,642.8325,000,00010,000,000
  收到其他与筹资活动有关的现金-1,052,017.971,052,017.971,052,017.97
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-94,048,560.887,156,317.9772,156,317.97
  偿还债务支付的现金750,00039,750,00039,750,00039,750,000
  分配股利、利润或偿付利息支付的现金76,759,807.0897,001,999.5197,437,481.6192,804,490.88
  支付其他与筹资活动有关的现金-95,433,152.9792,620,020.7791,745,891.73
  筹资活动现金流出小计77,509,807.08232,185,152.48229,807,502.38224,300,382.61
  筹资活动产生的现金流量净额-77,509,807.08-138,136,591.68-142,651,184.41-152,144,064.64
四、汇率变动对现金及现金等价物的影响--2,566.09-2,566.09-441.85
五、现金及现金等价物净增加额-46,981,468.38-57,929,440.09-367,922,167.95-366,389,011.37
  加:期初现金及现金等价物余额1,537,237,583.641,595,165,053.711,595,165,053.711,595,165,053.71
  期末现金及现金等价物余额1,490,256,115.261,537,235,613.621,227,242,885.761,228,776,042.34
补充资料:
  净利润-422,726,444.63-345,337,466.37
  资产减值准备-20,080,500.19-16,435,037.58
  固定资产和投资性房地产折旧-67,037,821.49-33,682,424.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,037,821.49-33,682,424.91
  无形资产摊销-8,270,050.87-4,085,575.62
  长期待摊费用摊销-651,149.45-195,215.94
  处置固定资产、无形资产和其他长期资产的损失--249,613.79-2,244,788.65
  固定资产报废损失-93,446.42--
  公允价值变动损失--2,105,592.51-197,794.77
  财务费用-2,268,891.66-1,284,520.32
  投资损失--324,770,617.56--315,674,594.19
  递延所得税--26,190,687.36--
  其中:递延所得税资产减少--25,144,691.32--
    递延所得税负债增加--1,045,996.04--
  存货的减少-11,279,585.29--2,650,403.49
  经营性应收项目的减少-78,873,514.42--29,321,854.53
  经营性应付项目的增加--30,470,666.72-11,867,838.06
  其他-15,866,320.98--
  现金的期末余额-1,537,235,613.62-1,228,776,042.34
  减:现金的期初余额-1,595,165,053.71-1,595,165,053.71
  现金及现金等价物的净增加额--57,929,440.09--366,389,011.37
公告日期2026-04-242026-03-252025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑